Shares of Gilead Sciences Inc. GILD shed 2.00% to $104.21 Tuesday, on what proved to be an all-around positive trading ...

Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the company of paying ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Gilead Sciences Inc. reached a $202 settlement with the US to resolve claims that it paid doctors and gave them meals and ...

The settlement, which calls for Gilead to pay the U.S. nearly $177 million and the balance to various states, was approved ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

(Nasdaq: GILD) announced today its first quarter 2025 results of operations. "Gilead had a strong start to the year driven by ...

The company's first-quarter revenue slipped 0.3% year-over-year to $6.67 billion, while analysts surveyed by Visible Alpha ...

As the Trump administration stares down diversity programs, this big Peninsula employer is highlighting its efforts.

Over the years, a host of large drugmakers have inked settlements with the federal authorities to resolve allegations that ...

The company paid to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV medicines.

ViiV leads the 2024/25 pharma company reputation rankings, with the PatientView report also finding ways in which the ...